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Imbalance in gut bacterial composition provokes
host proinflammatory responses causing diseases
such as colitis. Colonization with a mixture of
Clostridium species from clusters IV and XIVa was
shown to suppress colitis through the induction of
IL-10-producing regulatory T (Treg) cells.We demon-
strate that a distinct Clostridium strain from cluster I,
Clostridium butyricum (CB), prevents acute experi-
mental colitis in mice through induction of IL-10,
an anti-inflammatory cytokine. However, while
CB treatment had no effect on IL-10 production
by T cells, IL-10-producing F4/80+CD11b+CD11cint
macrophages accumulated in the inflamed mucosa
after CB treatment. CB directly triggered IL-10
production by intestinal macrophages in inflamed
mucosa via the TLR2/MyD88 pathway. The colitis-
preventing effect of CB was negated in macro-
phage-specific IL-10-deficient mice, suggesting that
induction of IL-10 by intestinal macrophages is
crucial for the probiotic action of CB. Collectively,
CB promotes IL-10 production by intestinal macro-
phages in inflamed mucosa, thereby preventing
experimental colitis in mice.
INTRODUCTION
The human gastrointestinal tract harbors approximately 1014
commensal bacteria of over 1,000 species. The profile of bacte-
rial species can vary between individuals and is determined by a
variety of factors (Gill et al., 2006; Honda and Littman, 2012; Ley
et al., 2006). Intestinal microbiota contribute to many host phys-
iological processes, including nutrient acquisition and develop-
ment of the gut-specific immune system, as well as protectionCell Hfrom infectious pathogens. The host in turn provides niches
and nutrients for the commensal bacteria (Garrett et al., 2010;
Hooper et al., 2012). To maintain the mutually beneficial relation-
ship between host and commensal microorganisms, the host
immune system shapes the compositional balance of symbiotic
commensal bacteria (Hooper et al., 2012). Recent studies have
revealed that an imbalance in the bacterial composition (dysbio-
sis) provokes host proinflammatory immune responses and
induces various inflammatory and metabolic diseases (Elinav
et al., 2011; Garrett et al., 2007; Vijay-Kumar et al., 2010).
In a conventional environment, the gut bacterial community
forms hierarchies in which only a selected group of bacteria
occupy the mucosal layer and surface of the epithelium; thus,
nonselected bacteria are expelled from the mucosal surface.
Competition in the bacterial community plays a pivotal role in
the prevention of pathogenic bacteria invasion. However, the
sequestration of microbiota confounds the immunological anal-
ysis of host versus specific bacteria. Recent advances in gnoto-
biotic technology have enabled analysis of the role of specific
bacterial strains in immunological responses (Chinen andRuden-
sky, 2012; Geuking et al., 2011; Tlaskalova´-Hogenova´ et al.,
2011). Using these techniques, a recent study reported that a
complex mixture of 46 strains of Clostridium induced TGF-b in
intestinal epithelial cells that promoted the subsequent accumu-
lation of interleukin-10 (IL-10)-producing induced T regulatory
(iTreg) cells, which suppressed colitis in a dextran sodium sulfate
(DSS) colitis model (Atarashi et al., 2011). However, T cells might
be dispensable for acute DSS colitis (Katakura et al., 2005),
bringing intoquestion the role of iTreg cells in theprobiotic effects
of Clostridium species.
Unlike the mixture of 46 strains of Clostridium in Clostridium
clusters IV and XIVa, Clostridium butyricum (CB), which is used
as a probiotic in clinical practice (Seki et al., 2003) is classified
in Clostridium cluster I and is a group member of allochthonous
bacteria in specific pathogen-free (SPF) conditions (Sato and
Tanaka, 1997). In the present study, we demonstrated that
administration of the probiotic bacterial strain CB prevented
experimental colitis via an IL-10-dependent mechanism. CBost & Microbe 13, 711–722, June 12, 2013 ª2013 Elsevier Inc. 711
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Figure 1. CB Monoassociation Suppresses the Development of Acute DSS-Induced Colitis
(A) Experimental design. GF mice were either untreated or orally inoculated with CB, and 1.0% DSS treatment followed.
(B) Scanning electron microscopy showing the distal colon of CB-monoassociated mice treated with DSS. Epi., epithelial cells; Muc., mucus.
(C and D) Body weight (C) and clinical score (D) on day 10. Each symbol represents an individual mouse; horizontal lines indicate the mean values.
(E) Colon length of each group.
(F) Histopathology of distal colon.
(G) Histological scores of the distal colon.
(H) LPMCs obtained from the colon were restimulated with heat-killed CB for 24 hr, and the culture supernatants were analyzed for IL-10 by CBA assay.
Error bars represent the mean ± SEM (n = 4–5 mice per group). *p < 0.05. NS, not significant. Original magnification,3100. The scale bar represents 100 mm. See
also Figure S1.
Cell Host & Microbe
IL-10-Producing Macrophages Induced by Clostridiuminduced IL-10 production by F4/80+CD11b+CD11cint intestinal
macrophages, but not CD4+ T cells, in inflamedmucosa, thereby
suppressing experimental colitis by an IL-10-dependent
mechanism.
RESULTS
CB Suppresses Development of Acute DSS-Induced
Colitis
Mounting evidence suggests that commensal Clostridium
strains havemajor effects on the development of the gut immune
system, thereby regulating gut homeostasis (Atarashi et al.,
2011; Ivanov et al., 2009). TheClostridium strainCB is a noncom-
mensal bacterium in the intestine yet has been used for various
human gastrointestinal diseases in clinical settings (Seki et al.,
2003). Although CB has a major impact on the treatment of
gastrointestinal diseases, the precise mechanism by which it
prevents disease remains to be elucidated. To determine
whether colonization by CB has an immunomodulatory role in
intestinal inflammation, we used DSS to induce acute colitis in
germ-free (GF) or CB-monoassociated mice (Figure 1A). We
confirmed that colonization of CB was retained in the distal
colon (the most inflamed area) even after DSS administration
(Figure 1B). Body weight (BW) of GF mice was significantly
reduced by DSS administration and was significantly attenuated
in CB-monoassociated mice (Figure 1C). As shown in Figure 1D,
monoassociation with CB significantly ameliorated the clinical712 Cell Host & Microbe 13, 711–722, June 12, 2013 ª2013 Elsevierscore compared with GF DSS mice. Macroscopic findings
showed bloody stools and shortened colon length in GF DSS
mice, which was reduced in CB-monoassociated mice (Fig-
ure 1E). Histological scoring confirmed the clinical improvement
due to CBmonoassociation (Figures 1F and 1G). Anti-inflamma-
tory effects of CBwere also observed in a different colitis model.
Similar to the acute DSS colitis model, CB treatment prevented
colitis development in an oxazolone-induced colitis model
(Figures S1A–S1F available online). Although CB exhibited a
colitis-preventing effect in two different experimental colitis
models, the mechanism by which CB suppressed colitis devel-
opment remains unclear. To address this, we isolated lamina
propria mononuclear cells (LPMCs) from inflamed colons, and
assessed cytokine profiles. Intriguingly, production of IL-10, an
anti-inflammatory cytokine, by LPMCs was greatly enhanced in
DSS-treated CB mice compared with other groups (Figure 1H),
suggesting that IL-10 production in the LP might play a role in
the therapeutic effect of CB.
Protective Effect of CB on DSS-Induced Colitis
Is Dependent on IL-10
To further examine the involvement of IL-10 in the anticolitic
effect of CB, we continuously administered neutralizing anti-
IL-10 monoclonal antibody (mAb) to DSS-treated SPF mice
with or without CB feeding (Figure 2A). Analysis of bacterial
DNA in feces showed that feeding with CB did not significantly
affect the representative species of microbiota resident in theInc.
Cell Host & Microbe
IL-10-Producing Macrophages Induced by Clostridiumcolon of SPF mice (Figure 2B). Interestingly, the anti-IL-10 mAb
treatment of DSS-administered mice, irrespective of CB admin-
istration, significantly decreased the amount of Clostridium
coccoides group and Clostridium leptum subgroup when
compared with paired mice without anti-IL-10 mAb treatment
(Figure 2B). In accordance with a previous report (Heimesaat
et al., 2007), the amount of Enterobacteriaceae, a pathological
bacterial candidate, was significantly increased after DSS
administration, but was not altered among DSS-administered
groups of mice (Figure 2B). DSS-administered mice developed
colitis as assessed by the bodyweight curve (Figure 2C), disease
activity index (DAI) (Figure 2D), colon length (Figure 2E), histolog-
ical findings (Figure 2F), and histological score (Figure 2G). Of
note, all of these manifestations of DSS-induced colitis were
significantly attenuated byCB feeding (Figures 2C–2G). Notably,
the protective effect of CB was completely abrogated by coad-
ministration of anti-IL-10 mAb, assessed with the above param-
eters (Figures 2C–2G), and in mice with similar levels of colitis
symptoms to those observed in anti-IL-10 mAb-treated and
DSS-administered mice. This confirmed the IL-10-dependent
probiotic effect of CB on colitis. These results, as well as the
monoassociation ofCB shown in Figure 1, indicated that the pro-
biotic effect of CB is not mediated through modification of the
commensal microbial community (e.g., increased anti-inflamma-
tory commensals or suppressed colitogenic pathobionts), but
rather through the direct induction of IL-10-mediated anti-inflam-
matory immunity by CB itself.
A Treg-Cell-Mediated Anti-inflammatory Role Might Be
Dispensable for the Suppression of Colitis by CB
Since a major protective effect of Clostridium strains against
colitis is mediated by the induction of IL-10-producing transcrip-
tion factor forehead box P3 (Foxp3)+ iTreg cells (Atarashi et al.,
2011), whether the anti-inflammatory effect of CB was mediated
through Treg cells was assessed. Unexpectedly, the frequency
and number of CD4+Foxp3+ Treg cells were not increased in
CB-treated mice compared with non-CB treatment group in
colitis conditions (Figures 3A and 3B). Instead, the frequency of
intestinal IL-10-expressing CD11b+F4/80+ macrophages in CB-
administered DSS mice was significantly increased compared
with that in DSS-administered mice or in mice that had not
been treated with DSS (Figure 3C). These results suggested
that CB could induce IL-10-producing macrophages but not
Tregcells in the inflamedcolon and that itmight regulate intestinal
inflammation through these regulatory cells. Although CB treat-
ment did not increase the number Foxp3+Treg cells in the
inflamed intestine, the functional involvement of Treg cells in
the suppression of colitis cannot be ruled out by only quantifica-
tion of cell numbers in the intestine. To address whether the anti-
inflammatory effect of CB was conserved in Treg-null mice, we
depleted CD4+CD25+ Treg cells by injection of anti-CD25 mAb
(PC61) and administered mice DSSwith or withoutCB treatment
(Figure 3D). We confirmed that the PC61 treatment protocol
induced CD4+CD25+ cell depletion in the spleen irrespective of
CB treatment (Figure 3E). Depletion of Treg cells by PC61 signif-
icantly worsened DSS colitis in terms of colon length and histol-
ogy/histological scores (Figures 3F–3I), suggesting that Treg
cells are partly involved in the prevention of acute DSS colitis.
Consistentwith our earlier observation,CB administration almostCell Hcompletely prevented DSS colitis in Treg-intact mice (Figures
3F–3I). Notably, CB administration significantly suppressed
colitis even in Treg-cell-depleted mice (Figures 3F–3I), suggest-
ing that CB might suppress intestinal inflammation by a Treg-
cell-independent anti-inflammatory mechanism. However, CB
administration did not fully prevent the development of colitis in
the absence of Treg cells (Figures 3F–3I), indicating that Treg
cells also have a partial role in the CB-mediated anti-inflamma-
tory effect.
Protective Effect of CB in DSS-Induced Colitis in Rag2–/–
Mice Is IL-10 Dependent
To confirm the T cell independent anti-inflammatory mechanism
of CB on colitis, we determined whether CB induced a sup-
pressive effect on colitis in T-cell-deficient conditions. It was
previously reported that recombination activating gene 2
(Rag-2)-deficient (Rag2/) mice developed colitis after DSS
administration (Katakura et al., 2005). As shown in Figure 4, CB
treatment significantly prevented DSS-induced colitis inRag2/
mice. Notably, this anti-inflammatory effect ofCBwas prevented
by the administration of IL-10 neutralizing antibody (Figures
4A–4F), suggesting that the anti-inflammatory effect was medi-
ated through the promotion of T-cell-independent IL-10 produc-
tion. Consistent with the in vivo results, CB induced robust IL-10
production in isolated colonic LPMCs from colitic Rag2/ mice
(Figure S2A). In addition, another commensal bacterial strain
Enterococcus faecalis (EF), induced a minimal amount of IL-10
isolated colonic LPMCs (Figure S2A). The CB-induced IL-10
productionwasobserved inCD11b+ cells but not inCD11b cells
from theLPMCs (FigureS2B).Moreover, flowcytometric analysis
indicated that a CD11b+CD11cint macrophage subset was
the major producer of IL-10 after CB stimulation (Figures S2C
and S2D).
CB Induces IL-10 Production by Macrophages
in Inflammatory Conditions
Next, we attempted to confirm IL-10 production by intestinal
macrophages in vivo using Il10Venus reporter mice. DSS colitis
was triggered in Il10 Venus reporter mice with or withoutCB treat-
ment. In the inflamed colonic LP, IL-10 (Venus) expression was
significantly enhanced in intestinal CD11b+CD11cint macro-
phages by CB administration, but not in CD4+ T cells (Figures
5A and 5B). Consistent with flow cytometric analysis, immuno-
histochemical analysis demonstrated the majority of IL-10-
Venus+ cells in the LP of CB-treated mice were CD11b+, but
not CD4+, cells (Figure 5C). We next confirmed IL-10 production
by CD11b+ macrophages in CB- or EF-stimulated LPMCs from
DSS-treated colitic Il10Venus mice. IL-10 production was mark-
edly induced in response to CB, but not EF, in colitis Il10Venus
CD11b+ CD11cint macrophages but not in CD4+ T cells and
Foxp3+CD4+ Treg cells (Figures 5D and 5E).
IL-10 Induction in CB-Stimulated Macrophages
Is TLR2-MyD88 Dependent
Taken together, the results suggested that CB treatment pro-
moted IL-10 production by intestinal macrophages in inflamed
mucosa. To determine whether CB-induced IL-10 secretion by
intestinal macrophages was directly induced by bacterial com-
ponents of CB or mediated through secreted metabolites ofost & Microbe 13, 711–722, June 12, 2013 ª2013 Elsevier Inc. 713
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Figure 2. Protective Effect of CB Treatment in DSS-Induced Colitis Is IL-10 Dependent
(A) Experimental design. SPF mice were treated with CB. After 1 week, neutralizing anti-IL-10 mAb or control IgG (0.4 mg/200 ml) were administered 2 hr before
1.0% DSS treatment and then every 48 hr.
(B) Bacterial DNA from the feces in each group of mice was extracted and analyzed by quantitative PCR (qPCR) for the 16S ribosomal RNA coding gene.
(C) Change in body weight.
(D and E) DAI score (D) and colon length (E) on day 10.
(legend continued on next page)
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A B C Figure 3. A Treg-Cell-Mediated Anti-inflam-
matory Role Might Be Dispensable for the
Suppression of Colitis by CB
SPF mice were treated with CB, followed by 1.0%
DSS treatment.
(A and B) The percentage (A) and absolute number
(B) of Foxp3+ cells in colonic LP CD3+CD4+ T cells.
(C) Statistical analysis of the percentages of IL-10+
CD11b+F4/80+ macrophages.
(D) Experimental design. SPF WT mice were
treatedwithCB. After 1 week, depleting anti-CD25
mAbs (PC61) or control IgGs (1 mg/500 ml) was
administered 1 day before and 4 days after 1.0%
DSS treatment.
(E) The percentage of CD25+ cells in splenic
CD3+CD4+ T cells.
(F and G) Representative gross appearance of
colon (F) and colon length (G) on day 10.
(H) Histopathology of distal colon.
(I) Histological score.
Error bars represent themean ± SEM (n = 4–5mice
per group). *p < 0.05. Original magnification,
3100. The scale bar represents 100 mm.
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IL-10-Producing Macrophages Induced by ClostridiumCB, we stimulated intestinal macrophages with heat-killed CB or
CB culture supernatant in vitro. IL-10 production by inflamed
colonic LPMCs was significantly induced by CB compared
with EF (Figure 6A). Although the culture supernatant from CB
slightly induced IL-10 by LPMCs, heat-killed bacteria was a
more potent inducer of IL-10 (Figure 6A). Since neither heat-
killed bacteria nor culture supernatant of EF inducedmeasurable
production of IL-10 by LPMCs compared with CB, bacterial
components specific to CB, but not EF, might be capable of
inducing IL-10. We further explored the mechanism by which
CB induced IL-10 from intestinal macrophages in inflammatory
conditions. Toll-like receptor 2 (TLR2) andmyeloid differentiation(F) Histopathology of distal colon.
(G) Histological score.
Error bars represent the mean ± SEM (n = 4–5 mice per group). *p < 0.05. NS, not significant; ND, not detec
represents 100 mm.
Cell Host & Microbe 13, 711–7factor 88 (MyD88) have been implicated
in the recognition of, and signaling in
response to, a variety of pathogen-asso-
ciated molecular patterns (PAMPs) from
gram-positive CB by innate immune cells
including macrophages. Therefore, we
isolated LPMCs from DSS-treated wild-
type (WT), Tlr2/, or Myd88/ mice
and stimulated them with heat-killed CB
or EF. Cytokine profiling showed that
CB induced significantly higher amounts
of IL-10 and lower amounts of interferon
g in WT LPMCs compared with EF
(Figure 6B). Of note, the induction of
these cytokines was almost completely
abolished in the absence of TLR2
or MyD88. These data suggest that
PAMPs from CB are required to induce
IL-10 production from intestinal macro-phages through the TLR2-MyD88 signaling pathway (Figures
6C and 6D).
IL-10 Production from Macrophages Is Responsible
for Protection against Colitis by CB
The results obtained suggested thatCB-treatment induced IL-10
secretion by intestinal macrophages, but not T cells, in the
inflamed colon. Although we demonstrated that IL-10 is the key
factor for the colitis-preventing effect ofCB and thatCB induced
IL-10 production by intestinal macrophages rather than T cells,
there is still no direct evidence that macrophage-produced
IL-10 prevents colitis after CB treatment. To address this, wetable. Original magnification, 3100. The scale bar
22, June 12, 2013 ª2013 Elsevier Inc. 715
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also Figure S2.
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IL-10-Producing Macrophages Induced by Clostridiumused macrophage-specific IL-10-deficient (Il10FL/FL lysM-Cre+)
mice and administeredDSS toCB-fed Il10FL/FLCre and Il10FL/FL
lysM-Cre+ mice (Figure 7A). CB-fed Il10FL/FL Cre mice showed
significantly improved DSS colitis in terms of weight loss (Fig-
ure 7B), colon length (Figure 7C), and histological findings/score
(Figures 7Dand 7E). In contrast, the protective effects ofCBwere
canceled in Il10FL/FL lysM-Cre+mice (Figures 7B–7E), suggesting
that IL-10 production by macrophages was crucial for the pre-
vention of colitis by CB. Consistent with this in vivo phenotype,
CB-stimulated LPMCs from Il10FL/FLCremice produced robust
amounts of IL-10, while limited amounts of IL-10 were observed
in CB-stimulated LPMCs from Il10FL/FL lysM-Cre+ mice (Fig-
ure 7F). Next, the adoptive transfer of LP CD11b+ cells was as-
sessed to confirm the role of IL-10 production by macrophages
to control colitis. We obtained colitic LP CD11b+ cells from WT
and Il10/mice stimulated with or withoutCB in vitro and trans-
ferred them into DSS-treated WT mice (Figure 7G). Adoptive
transfer of CB-stimulated WT macrophages but not of unstimu-
lated WT macrophages significantly improved colitis (Figures
7H–7L). In contrast, when LP macrophages from Il10/ mice
were transferred, in vitro CB treatment failed to ameliorate the
severity of DSS colitis (Figures 7H–7L). Taken together, these
data indicated that IL-10 production by macrophages is indis-
pensable for CB’s probiotic effects against colitis.716 Cell Host & Microbe 13, 711–722, June 12, 2013 ª2013 ElsevierDISCUSSION
Although emerging evidence shows that specific commensal
bacteria can affect the differentiation of mucosal Th17 and iTreg
cells under normal conditions (Atarashi et al., 2011; Geuking
et al., 2011; Ivanov et al., 2009; Littman and Pamer, 2011;
O’Mahony et al., 2008; Round et al., 2011), it has remained
largely unknown which specific bacteria influence mucosal-
specific antigen-presenting cell (APC) phenotypes. Here we
demonstrated that CB induced the production of IL-10 by
colonic F4/80+CD11b+CD11cint macrophages rather than Treg
cells in inflammatory conditions and suppressed acute experi-
mental colitis in an IL-10-dependent manner.
IL-10 has important roles in the regulation of gut homeostasis
during host defense (Maloy and Powrie, 2011; Maynard et al.,
2007). The association between IL-10 and inflammatory bowel
disease (IBD) has been demonstrated by several findings in
both humans and in animal models. For example, Il10/ mice
spontaneously develop colitis in the presence of commensal
bacteria (Ku¨hn et al., 1993; Spencer et al., 1998), while a
genome-wide association study in humans has shown that a
single-nucleotide polymorphism in the Il10 gene is closely asso-
ciated with IBD (Franke et al., 2008). In this regard, various
immune cell types produce IL-10 in the gut. Treg cells are amajorInc.
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Figure 5. CB Induces IL-10 Production by Macrophages in
Inflammatory Conditions
(A) LPMCs fromDSS-administered Il10Venus mice with or withoutCB treatment
were isolated, and IL-10 (Venus) expression was determined in CD3+CD4+
T cells (top) and CD11b+ macrophages (bottom).
(B) Statistical analysis of the percentages of IL-10 (Venus)+ in CD3+CD4+
T cells (top) and IL-10 (Venus)+ in CD11b+CD11cint cells (bottom).
(C) Immunohistochemistry of CD11b (red)/IL-10 (Venus) (left) and CD4 (red)/
IL-10 (Venus) (right) in the colon of DSS-administered Il10Venus mice with CB
treatment.
(D) LPMCs from colitic DSS (+) SPF Il10Venus mice were cultured without (Med)
or with heat-killed CB or EF for 24 hr. Expression of Venus (IL-10) in CD4+
T cells, Foxp3+CD4+ T cells, and CD11b+ macrophages from colitic Il10Venus
mice is shown.
(E) Statistical analysis of the percentages of IL-10+ cells in CD3+CD4+ T cells
(top), IL-10+ cells in Foxp3+CD3+CD4+ T cells (middle) and IL-10+ cells in
CD11b+CD11cint cells (bottom).
Data are representative of three independent experiments. Error bars repre-
sent the mean ± SEM of triplicates. *p < 0.05. int, intermediate; NS, not
significant.
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Cell Hsource of IL-10 in the gut (Honda and Littman, 2012; Maynard
et al., 2007), and Treg-specific Il10/ mice spontaneously
develop colitis, indicating the importance of Treg-derived IL-10
in the suppression of colitis (Roers et al., 2004; Rubtsov et al.,
2008).
A recent report demonstrated that colonization of GF mice
with a mixture of 46 Clostridium cluster IV and XIVa strains pro-
moted the accumulation of IL-10-producing iTreg cells in the
colon and induced resistance to acute DSS-induced colitis.
Thus, a diverse set of metabolites produced by these 46 strains
ofClostridiummight be required for the optimal induction of iTreg
cells (Atarashi et al., 2011).
Unlike these commensal Clostridium strains, the probiotic
Clostridium strain CB primarily induced IL-10 production from
colonic F4/80+CD11b+CD11cint intestinal macrophages rather
than Foxp3+ Treg cells and prevented experimental colitis. In
addition to Treg cells, intestinal mononuclear phagocytes,
such as intestinal macrophages, are major producers of IL-10
and play pivotal roles in the regulation of intestinal homeostasis
and inflammation (Liu et al., 2011). Yet the responsible
commensal bacterial strains remain unidentified, although it
was reported that IL-10 production by intestinal macrophages
was enhanced by colonization with commensal microbiota (Riv-
ollier et al., 2012; Ueda et al., 2010). However, unlike these
unidentified commensal bacteria, monoassociation of CB in
GF mice failed to increase the production of IL-10 by intestinal
macrophages in the steady state (data not shown). However, in
inflamed mucosa, CB directly stimulated intestinal macro-
phages through the TLR2/MyD88 signaling pathway and
induced IL-10 production by macrophages, suggesting that
CB preferentially induces IL-10 by newly recruited and/or prolif-
erating macrophages during intestinal inflammation but does
not activate resident macrophages in the intestine. This possi-
bility is also supported by evidence that resident intestinal mac-
rophages are hyporesponsive to microbial stimulation, including
TLR2 ligands (Mowat and Bain, 2011), while newly recruited
inflammatory monocytes and macrophages during inflamma-
tion can respond to these bacterial ligands (Murray and Wynn,
2011; Smith et al., 2011). Thus, this difference in responsive-
ness to microbial ligands between resident and inflammatory
macrophages might explain the failed induction of macro-
phage-mediated IL-10 production by CB under physiological
conditions.
The role of bacterial pattern recognition receptor signaling in
commensal bacteria-mediated development of anti-inflamma-
tory immunity is controversial for each bacterium. MyD88
signaling is dispensable for Foxp3+ Treg induction by cocktail
of 46 Clostridium species, whereas Treg induction by colo-
nization with a cocktail of eight defined commensals, called
altered Schaedler flora, is MyD88 dependent (Atarashi et al.,
2011; Geuking et al., 2011). A human commensal bacterium,
Bacteroides fragilis, promoted IL-10-producing Tregs and/or
macrophages through the TLR2 dependent pathway that was
activated by its outer membrane vesicle component polysac-
charide A (PSA) (Cohen-Poradosu et al., 2011; Mazmanian
et al., 2008; Round et al., 2011; Shen et al., 2012). In the present
study, we demonstrated that CB could induce IL-10 from
intestinal macrophages through the TLR2/MyD88-mediated
pathway. Although the precise active component of CB isost & Microbe 13, 711–722, June 12, 2013 ª2013 Elsevier Inc. 717
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Figure 6. IL-10 Induced in CB-Stimulated Macrophages Is
TLR2-MyD88 Dependent
(A) LPMCs from colitic DSS-administered mice were cultured with heat-killed
CB or EF, or supernatant of cultured CB or EF for 24 hr. IL-10 concentrations
were determined by CBA assay.
(B) LPMCswere isolated fromDSS-treatedWT, Tlr2/, orMyd88/mice and
stimulated without (Med) or with heat-killed CB or EF for 24 hr. IL-10 in the
culture supernatants was measured by CBA assay.
(C) Intracellular IL-10 in CD11b+F4/80+ macrophages was analyzed by flow
cytometry.
(D) Statistical analysis of the percentages of IL-10+ cells in CD11b+F4/80+
macrophages.
Data are representative of three independent experiments. Error bars repre-
sent the mean ± SEM. *p < 0.05. NS, not significant; ND, not detectable.
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may include secreted components and/or metabolites, induced
IL-10 production bymacrophages by the TLR2/MyD88 pathway.
Unlike CB, an anti-inflammatory subset of human commensal
Clostridium leptum group strains, Faecalibacterium prausnitzii,
secretes its active component into culture supernatant, such
that culture supernatant of F. prausnitzii prevents colitis through
the induction of IL-10 (Sokol et al., 2008). Thus, certain kinds of
anti-inflammatory commensal microbiota and probiotic bacteria
might harbor a specific structure to promote IL-10 production by
T cells and/or non-T cells, thus regulating gut homeostasis and
intestinal inflammation.
It is noteworthy that in addition to individual immune regulatory
functions of IL-10-producing T cells or non-T cells, interplay
between IL-10-producing T cells and IL-10-producing non-T
cells is also important for the regulation of immune homeosta-
sis and disease suppression. It was reported that intestinal
F4/80+CD11b+ macrophages can promote IL-10-producing
Foxp3+ Treg development by an IL-10-mediated mechanism
(Denning et al., 2007). In addition to the homeostatic immune
responses, IL-10 secretion by dendritic cells (DCs) is required
for the induction of IL-10-producing T cell development and pre-
vention of colitis by B. fragilis PSA (Shen et al., 2012). Likewise,
the anticolitic effect of phosphoglycerol transferase gene-
deleted Lactobacillus acidophilus was negated by depletion of
Treg cells with anti-CD25 antibody (PC61) treatment, despite
this bacterial strain inducing IL-10 from either DCs or Treg cells
(Mohamadzadeh et al., 2011). In the current study, macro-
phage-specific IL-10 depletion and IL-10-deficient macrophage
adoptive transfer experiments strongly suggested that IL-10
production by intestinal macrophages was the key factor for
CB-mediated anti-inflammatory effects. However, although CB
treatment induced an anti-inflammatory effect in Treg-cell-
depleted mice, CB failed to prevent colitis completely in these
mice. This indicated a potential pathway where IL-10 produced
by CB-treated intestinal macrophages might contribute to
further anti-inflammatory responses by inducing IL-10-produc-
ing Treg cells.
Probiotic treatment is an effective treatment option for gastro-
intestinal disorders, including IBD (Sartor, 2004). A major thera-
peutic effect of probiotics is mediated by their metabolites,
such as oligosaccharides and short-chain fatty acids (Macia
et al., 2012). Metabolites produced by probiotic bacterial strains
improve the ecosystem of the intestinal tract via promoting the
growth of healthy symbionts and/or enhancing the barrier func-
tion of epithelial cells (Round and Mazmanian, 2009). However,
in this study, CB administration did not alter the composition of
gut microbiota in DSS-treated mice, suggesting that the sup-
pressive effect of CB on DSS-induced colitis was not mediated
by altered commensal bacteria composition. Furthermore, the
ability of CB to increase IL-10 production from macrophages
was not due to metabolites produced by live CB. Commensal
bacterial strains are thought to be innocuous in the healthy intes-
tinal tract; however, it is evident that inflammatorymacrophages,
which accumulate in the intestine of IBD patients, robustly
respond to commensal bacteria and produce proinflammatory
cytokines, such as IL-23 and tumor necrosis factor a (Kamada
et al., 2008). This evidence suggests commensal bacteria might
penetrate the LP, and thus enhance pathogenic responses, inInc.
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that this might worsen intestinal inflammation. Because CB
induced an IL-10-mediated immune-suppressive effect even
under inflammatory conditions, CBmight be a ‘‘safer’’ therapeu-
tic option as a probiotic bacterium for the treatment of IBD
patients experiencing an active inflammatory phase.
Collectively, these findings clarify the role of a probiotic strain
of Clostridium species, CB, which regulates IL-10 production by
intestinal macrophages in inflamed mucosa and prevents the
development of colitis.
EXPERIMENTAL PROCEDURES
Animals
C57BL/6 mice were purchased from Japan Clea, and Rag2/ mice were
obtained from Taconic Laboratory and Central Laboratories for Experi-
mental Animals. Il10/ C57BL/6 mice were purchased from Jackson Labora-
tories. Il10Venus mice were previously described (Atarashi et al., 2011).
Il10FL/FLlysM-Cre+mice were established previously (Roers et al., 2004; Siewe
et al., 2006). Tlr2/mice were purchased fromOriental Bio Service.Myd88/
mice were a kind gift from Dr. Shizuo Akira (Osaka University). GF C57BL/6
mice were purchased from Sankyo Laboratories (Supplemental Experimental
Procedures). All experiments were approved by the regional animal study
committees and were performed according to institutional guidelines.
Heat-Killed Bacteria and Culture Supernatants
A gram-positive commensal strain of EF (catalog number 29212; American
Type Culture Collection) was cultured in brain-heart infusion (BHI) medium.
Clostridium butyricum MIYAIRI 588 used in this study was obtained from
Miyarisan Pharmaceutical (Supplemental Experimental Procedures). EF or
CB was cultured in BHI medium. After 24 hr culture at 37C, the culture broth
was centrifuged at 6,0003 g for 10min and filtrated through a 0.2 mmfilter. The
supernatants were collected and stored at –80C.
Tissue Preparations
Intestinal LPMCswere prepared as previously described (Totsuka et al., 2008),
with slight modifications (Supplemental Experimental Procedures). LPCD11b+
and CD11b cells were obtained by positive selection with anti-CD11b MACS
beads. The resultant cells analyzed by a FACSCanto II (Becton Dickinson)
contained >95% CD11b+ cells.
Stimulation of LPMC
LPMCs were seeded on 96-well tissue culture plates (1 3 106 cells/ml) and
stimulated with each strain of heat-killed bacteria (1 3 107 cells/ml) for 24 hr
at 37C in a humidified incubator with 5% CO2. For measurement of secreted
cytokines, culture supernatants were collected and stored at –80C.
DSS-Induced Colitis
For induction of acute experimental colitis, SPF or GF C57BL/6 background
WT, Myd88/, Tlr2/, Il10/, Il10venus, or Rag2/ mice received
1.0%–2.0% DSS (molecular weight 50 kDa; Ensuiko) dissolved in sterile
distilled water ad libitum. GF WT mice were inoculated with a single CB
(13 108 cells/200 ml). Three weeks after inoculation, GF and CB-monoassoci-
ated mice were administered 1.0% DSS for 7 days followed by regular
drinking water for 3 days. SPF mice were fed a normal diet or a diet containing
5 3 108 colony-forming units/g CB. After 1 week, mice were administered
1.0% DSS for 7 days followed by regular drinking water for 3 days (Supple-
mental Experimental Procedures). Mice were weighed daily and visually
inspected for diarrhea and rectal bleeding. The DAI was assessed blinded to
the mouse groups (Siegmund et al., 2001) (Supplemental Experimental
Procedures).
Oxazolone-Induced Colitis
Acute Oxazolone colitis was induced as previously described (Wirtz
et al., 2007). In brief, C57BL/6 mice were presensitized with 150 ml 3% oxa-
zolone (Sigma-Aldrich) in 100% ethanol. Seven days after presensitization,Cell Hmice were rechallenged intrarectally with 100 ml 1% oxazolone in 50%
ethanol.
Clinical and Histological Scorings of Colitis
All mice were observed for clinical signs such as hunched posture, piloerec-
tion, diarrhea, and blood in the stool. The clinical score of mice was assessed
at autopsy (Mikami et al., 2010). Histological activity score (Mennigen et al.,
2009) (maximum total score 40) was assessed as the sum of three parameters,
extent, inflammation, and crypt damage as described in the Supplemental
Experimental Procedures.
Electron Microscopy
Dissected 0.5 cm pieces of the colon were cut open and fixed with 2% para-
formaldehyde/2% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) at 4C
overnight. The samples were fixed with 2% osmium tetroxide in 0.1 M phos-
phate buffer at 4C for 2 hr and were then dehydrated through a series of
graded ethanol wash steps for scanning electron microscopy. The samples
were transferred into tert-butyl alcohol three times for 30 min each and frozen
at 4C. After drying, the samples were coated with a thin layer (35 nm) of
osmium with an osmium plasma coater (NL-OPC80NS, Nippon Laser & Elec-
tronics Laboratory). The samples were observed with a scanning electron
microscope (S-800, Hitachi) at an acceleration voltage of 10 kV, and images
were captured with a digital camera.
Immunohistochemistry
Consecutive cryostat colon sections were used for immunohistochemistry
with purified rat anti-CD4 (RM4-5; BD PharMingen), rat anti-CD11b (M1/70;
Abcam) and rabbit anti-GFP (green fluorescent protein; MBL) mAb. In brief,
tissue samples were fixed in PBS containing 4% paraformaldehyde for 2 hr
and were then placed in PBS containing 15% sucrose overnight, replaced
in PBS containing 30% sucrose overnight, mounted in optimal cutting
temperature (OCT) embedding compound, and frozen at 80C. OCT-
embedded tissue samples were cut into 10-mm-thick serial sections, placed
on coated slides, and fixed with 2% paraformaldehyde phosphate buffer
solution for 5 min. Slides were then incubated with the primary antibody at
room temperature for 2 hr and stained with Alexa Fluor 568 goat anti-
rat IgG (Invitrogen) for CD4 and CD11b detection and with Alexa Fluor 488
goat anti-rabbit IgG (Invitrogen) for GFP detection at room temperature for
2 hr. All slides were counterstained with Hoechst (Invitrogen) and observed
by confocal microscopy.
Flow Cytometry
For surface and intracellular staining, we used the same protocol as previously
described (Atarashi et al., 2011) (Supplemental Experimental Procedures).
FITC-, PE-, PerCP-Cy5.5-, APC-, PE-Cy7-, APC-Cy7- or Alexa Fluor 647-
conjugated mAbs against CD11c (HL3), CD3 (145-2C11), and CD4 (RM4-5)
were from BD Biosciences, CD11b (M1/70), F4/80 (BM8), Foxp3 (FJK-16S),
and IL-10 (JES5-16E3) were from eBioscience, and CD25 (PC61) was from
BioLegend (Supplemental Experimental Procedures).
Cytokine Assay
A mouse inflammatory cytometric bead array (CBA) kit (BD Biosciences) was
used for cytokine measurements, according to the manufacturer’s instruc-
tions. Samples were analyzed with a FACSCanto II flow cytometer (BD
Biosciences).
Fecal DNA Extraction for qPCR
Bacterial genomic DNA was extracted from fecal pellets with phenol-chloro-
form extraction as previously reported (Matsuki et al., 2004). qPCR analysis
was performed with a Thermal Cycler Dice Real Time System TP800 (Takara).
The primer sets used in this study are described in the Supplemental Experi-
mental Procedures.
Statistical Analysis
The results are expressed as mean ± SEM. Groups of data were compared
with the Mann-Whitney U test, Tukey-Kramer test, and Student’s t test. Differ-
ences were considered to be statistically significant when p < 0.05.ost & Microbe 13, 711–722, June 12, 2013 ª2013 Elsevier Inc. 719
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Figure 7. Macrophage-Specific IL-10 Deficiency Negated the Probiotic Effect of CB
(A) Experimental design 1. Il10FL/FL Cre and Il10FL/FL lysM-Cre+ mice were treated with CB, followed by 1.0% DSS treatment.
(B) Change in body weight.
(C) Colon length on day 10.
(D) Histopathology of distal colon.
(E) Histological score.
(F) Colitic LPMCs obtained from Il10FL/FL Cre and Il10FL/FL lysM-Cre+mice were stimulated with or without heat-killed CB for 24 hr, and the culture supernatants
were analyzed for IL-10 by CBA assay.
(G) Experimental design 2. LP CD11b+macrophages isolated fromWT and Il10/mice treated with DSSwere stimulated with or withoutCB for 24 hr in vitro. The
stimulated macrophages (1 3 106 cells/100 ml) were intravenously injected into WT mice on 1 day before and 4 days after 1.0% DSS treatment.
(H) Change in body weight.
(I and J) DAI score (I) and colon length (J) on day 10.
(legend continued on next page)
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